INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 459m ago
House PTR59m ago
SEC 13F58m ago
Robinhood Chain58m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JJ
Jones Jeffrey J IIDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
2,067 sh
Jan 21, 2026Jan 23, 2026
Page 1413 of 1790
← PrevNext →
traded Jan 21, 2026
+2d
SEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,401 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
NK
Norrett KevinChief Business Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
4,000 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
2,475 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BE
Buck ElizabethCHIEF SCIENTIFIC OFFICER
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
250.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HC
Hirano Patricia CSEE REMARKS
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
11.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WC
Wiese ChristopherPresident, Energy Vault Labs
NRGVEnergy Vault Holdings, Inc.
Tax withholding
F$31K
6,808 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
JM
Joshi ManherChief Development Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
4,700 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M$28K
522 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
JE
Jones ErikaSEE REMARKS
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
200.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,329 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$8,756
1,169 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$33K
72.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SL
Spikner Pamela L.SVP Controller & CAO
BDXBECTON DICKINSON & CO
Tax withholding
F—
84 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
32.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$26K
41.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$6,367
850 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$8,305
166.1K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$29K
3,827 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
940 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
850 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
VA
Velleca Mark A.Director, PRESIDENT & CEO
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
600.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
YS
Yurasov SergeyCHIEF MEDICAL OFFICER
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
250.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
MJ
Merkel JasonVP - Distribution
NWENorthWestern Energy Group, Inc.
Tax withholding
F$13K
206 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SB
Streeter Jeffrey BDirector
CHMGCHEMUNG FINANCIAL CORP
Grant or award
A$33K
574 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
TJ
Thompson Amanda JChief People Officer
GAPGAP INC
Disposition to issuer
D—
3,034 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
650 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
1,335 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
TD
Townsell DonnaDirector, Director of Investor Relations
HOMBHOME BANCSHARES INC
Option exercise
M—
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
KR
Kushel J. RichardSenior Managing Director
BLKBlackRock, Inc.
Option exercise
M—
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
LM
Leibman MayaDirector
AYIACUITY INC. (DE)
Grant or award
A—
546 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HP
Horowitz Jeff PeterChief Compliance Officer
BTGOBITGO HOLDINGS, INC.
Disposition to issuer
D—
15.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
VJ
Vold JeanneVP - Technology
NWENorthWestern Energy Group, Inc.
Tax withholding
F$14K
223 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence